Yuan J, Gong J, Peng Z, Liu TS, et al. Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial. Br J Cancer 2026;135:924-930.
PMID: 42337043